All Stories

  1. Surface functionalization by covalent immobilization of an innovative carvacrol derivative to avoid fungal biofilm formation
  2. A mechanically interlocked molecular system programmed for the delivery of an anticancer drug
  3. A dendritic β-galactosidase-responsive folate–monomethylauristatin E conjugate
  4. Evaluation of Cytotoxic Properties of a Cyclopamine Glucuronide Prodrug in Rat Glioblastoma Cells and Tumors
  5. ChemInform Abstract: β-Glucuronidase-Responsive Prodrugs for Selective Cancer Chemotherapy: An Update
  6. β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: An update
  7. Oxidative decarboxylation of diclofenac by manganese oxide bed filter
  8. Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy
  9. A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts
  10. An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification process
  11. NDMA Formation by Chloramination of Ranitidine: Kinetics and Mechanism
  12. Inside Cover: The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy (Angew. Chem. Int. Ed. 46/2012)
  13. Innentitelbild: The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy (Angew. Chem. 46/2012)
  14. The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy
  15. The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy
  16. 199 Cytotoxic Activity of a Cyclopamine Glucuronide Prodrug Against Glioblastoma Cells
  17. Synthesis and Antitumor Efficacy of a β-Glucuronidase-Responsive Albumin-Binding Prodrug of Doxorubicin
  18. Second generation specific-enzyme-activated rotaxane propeptides
  19. A self-immolative dendritic glucuronide prodrug of doxorubicin
  20. Formal synthesis of TMC-69-6H via a one-pot enantioselective domino proline-mediated aldol/olefin homologation procedure
  21. Inside Cover: A Heterodimeric Glucuronide Prodrug for Cancer Tritherapy: the Double Role of the Chemical Amplifier (ChemMedChem 12/2011)
  22. A Heterodimeric Glucuronide Prodrug for Cancer Tritherapy: the Double Role of the Chemical Amplifier
  23. A Galactosidase-Responsive “Trojan Horse” for the Selective Targeting of Folate Receptor-Positive Tumor Cells
  24. A new cyclopamine glucuronide prodrug with improved kinetics of drug release
  25. ChemInform Abstract: A New Spacer Group Derived from Arylmalonaldehydes for Glucuronylated Prodrugs.
  26. Dietary docosahexaenoic acid proposed to sensitize breast tumors to locally delivered drug
  27. Study of a cyclopamine glucuronide prodrug for the selective chemotherapy of glioblastoma
  28. ChemInform Abstract: Cyanuric Chloride: An Efficient Reagent for the Lossen Rearrangement.
  29. Cyanuric chloride: an efficient reagent for the Lossen rearrangement
  30. Rotaxane-Based Propeptides: Protection and Enzymatic Release of a Bioactive Pentapeptide
  31. Rotaxane-Based Propeptides: Protection and Enzymatic Release of a Bioactive Pentapeptide
  32. Synthesis and biological evaluation of glucuronide prodrugs of the histone deacetylase inhibitor CI-994 for application in selective cancer chemotherapy
  33. Design of Self-Immolative Linkers for Tumour-Activated Prodrug Therapy
  34. Design of Self-Immolative Linkers for Tumour-Activated Prodrug Therapy
  35. Efficient Regio- and Stereoselective Synthesis of 1-β-O-Glucuronyl Carbamates and Carbonates from Unprotected 1,2,3,4-Hydroxyl Glucuronates.
  36. First O-Glycosylation of Hydroxamic Acids.
  37. Efficient Regio- and Stereoselective Synthesis of 1-β- O -Glucuronyl Carba­mates and Carbonates from Unprotected 1,2,3,4-Hydroxyl Glucuronates
  38. First O -Glycosylation of Hydroxamic Acids
  39. Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) β-glucuronide and β-galactoside for application in selective prodrug chemotherapy
  40. A New Simple and Convenient Method for the Synthesis of Substituted 2,6,9-Trioxabicyclo[3.3.1]-nona-3,7-dienes from Arylmalondialdehydes.
  41. A new simple and convenient method for the synthesis of substituted 2,6,9-trioxabicyclo[3.3.1]-nona-3,7-dienes from arylmalondialdehydes
  42. Alchimies futures : compte rendu de l'expérience ESYOP
  43. Synthesis and Evaluation of p-Nitrophenylβ-D-Glucopyranosiduronic Analogues as New Triggers for β-Glucuronidase Mediated Prodrug Mono- Therapy
  44. Design of Selectively Activated Anticancer Prodrugs: Elimination and Cyclization Strategies
  45. Synthesis and β-Glucuronidase Mediated Cleavage of an Alcohol Prodrug Incorporating a Double Spacer Moiety
  46. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice
  47. ChemInform Abstract: Enantioselective Synthesis of Sulindac.
  48. Synthesis of indomethacin analogues for evaluation as modulators of MRP activity
  49. Synthesis and cytotoxic activity of a glucuronylated prodrug of nornitrogen mustard
  50. Study of biscarbamates derived from 2-aminobenzylamines as models for alcohol prodrugs
  51. A new spacer group derived from arylmalonaldehydes for glucuronylated prodrugs